InsidersTradesSigma
Track the 小林製薬株式会社 stock price and the full insider trade history of the company, a publicly traded company based in Japan. Shares are quoted on JP JP, under the oversight of EDINET (Japan FSA). Market capitalisation: €404.3bn. The latest transaction was reported on 26 December 2025 (Holding update). Among the most active insiders: Oasis Management Company Ltd.. All data is accessible without an account.
Analysts rate 小林製薬株式会社 Hold (neutral), based on 8 analysts. Average price target: JP¥5,496.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
3 of 3 declarations
Kobayashi Pharmaceutical Co., Ltd. is a Japanese company that specializes in the manufacturing of pharmaceutical and healthcare products. It is listed on the Tokyo Stock Exchange under the symbol XTKS.